EVOLUS, INC. Increase (Decrease) in Prepaid Expense
EVOLUS, INC. (EOLS) reported Increase (Decrease) in Prepaid Expense of $708.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpense · last filed 2026-08-05
- EVOLUS, INC. increase (decrease) in prepaid expense for the quarter ending 2026-06-30 was -$165.00K, a 112.31% decline year-over-year.
- EVOLUS, INC. increase (decrease) in prepaid expense for the quarter ending 2026-03-31 was $873.00K, a 747.57% increase year-over-year.
- EVOLUS, INC. increase (decrease) in prepaid expense for the quarter ending 2025-12-31 was -$900.00K.
- EVOLUS, INC. increase (decrease) in prepaid expense for the quarter ending 2025-09-30 was -$188.00K.
- EVOLUS, INC. increase (decrease) in prepaid expense for fiscal 2025 was $355.00K.
- EVOLUS, INC. increase (decrease) in prepaid expense for fiscal 2024 was -$2.35M, a 230.76% decline from fiscal 2023.
- EVOLUS, INC. increase (decrease) in prepaid expense for fiscal 2023 was $1.80M.
- EVOLUS, INC. increase (decrease) in prepaid expense for fiscal 2022 was -$1.18M, a 564.57% decline from fiscal 2021.
| Period end | Increase (Decrease) in Prepaid Expense 3 month | Increase (Decrease) in Prepaid Expense 6 month | Increase (Decrease) in Prepaid Expense 9 month | Increase (Decrease) in Prepaid Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$165.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $708.00K 10-Q · filed 2026-08-05 | -$192.00K derived: sum of 3 quarters · filed 2026-08-05 | -$380.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $873.00K 10-Q · filed 2026-05-04 | -$27.00K derived: sum of 2 quarters · filed 2026-05-04 | -$215.00K derived: sum of 3 quarters · filed 2026-05-04 | $1.13M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | -$900.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | -$1.09M derived: sum of 2 quarters · filed 2026-03-03 | $252.00K derived: sum of 3 quarters · filed 2026-08-05 | $355.00K 10-K · filed 2026-03-03 |
| 2025-09-30 | -$188.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $1.15M derived: sum of 2 quarters · filed 2026-08-05 | $1.25M 10-Q · filed 2025-11-05 | $1.21M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $1.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $1.44M 10-Q · filed 2026-08-05 | $1.39M derived: sum of 3 quarters · filed 2026-08-05 | -$715.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $103.00K 10-Q · filed 2026-05-04 | $53.00K derived: sum of 2 quarters · filed 2026-05-04 | -$2.06M derived: sum of 3 quarters · filed 2026-05-04 | -$2.23M derived: sum of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | -$50.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | -$2.16M derived: sum of 2 quarters · filed 2026-03-03 | -$2.33M derived: sum of 3 quarters · filed 2026-03-03 | -$2.35M 10-K · filed 2026-03-03 |
| 2024-09-30 | -$2.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$2.28M derived: sum of 2 quarters · filed 2025-11-05 | -$2.30M 10-Q · filed 2025-11-05 | -$256.00K derived: sum of 4 quarters · filed 2026-03-03 |
| 2024-06-30 | -$171.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | -$193.00K 10-Q · filed 2025-08-05 | $1.85M derived: sum of 3 quarters · filed 2026-03-03 | $1.21M derived: sum of 4 quarters · filed 2026-03-03 |
| 2024-03-31 | -$22.00K 10-Q · filed 2025-05-07 | $2.02M derived: sum of 2 quarters · filed 2026-03-03 | $1.38M derived: sum of 3 quarters · filed 2026-03-03 | $1.52M derived: sum of 4 quarters · filed 2026-03-03 |
| 2023-12-31 | $2.04M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $1.40M derived: sum of 2 quarters · filed 2026-03-03 | $1.54M derived: sum of 3 quarters · filed 2026-03-03 | $1.80M 10-K · filed 2026-03-03 |
| 2023-09-30 | -$642.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | -$504.00K derived: sum of 2 quarters · filed 2024-11-06 | -$247.00K 10-Q · filed 2024-11-06 | -$1.00K derived: sum of 4 quarters · filed 2025-03-04 |
| 2023-06-30 | $138.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | $395.00K 10-Q · filed 2024-07-31 | $641.00K derived: sum of 3 quarters · filed 2025-03-04 | -$3.11M derived: sum of 4 quarters · filed 2025-03-04 |
| 2023-03-31 | $257.00K 10-Q · filed 2024-05-07 | $503.00K derived: sum of 2 quarters · filed 2025-03-04 | -$3.25M derived: sum of 3 quarters · filed 2025-03-04 | -$374.00K derived: sum of 4 quarters · filed 2025-03-04 |
| 2022-12-31 | $246.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | -$3.50M derived: sum of 2 quarters · filed 2025-03-04 | -$631.00K derived: sum of 3 quarters · filed 2025-03-04 | -$1.18M 10-K · filed 2025-03-04 |
| 2022-09-30 | -$3.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$877.00K derived: sum of 2 quarters · filed 2023-11-07 | -$1.43M 10-Q · filed 2023-11-07 | -$828.00K derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $2.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $2.32M 10-Q · filed 2023-08-02 | $2.92M derived: sum of 3 quarters · filed 2023-08-02 | $1.67M derived: sum of 4 quarters · filed 2023-08-02 |
| 2022-03-31 | -$549.00K 10-Q · filed 2023-05-09 | $49.00K derived: sum of 2 quarters · filed 2023-05-09 | -$1.20M derived: sum of 3 quarters · filed 2023-05-09 | -$931.00K derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $598.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08 | -$655.00K derived: sum of 2 quarters · filed 2023-03-08 | -$382.00K derived: sum of 3 quarters · filed 2023-03-08 | $254.00K 10-K · filed 2023-03-08 |
| 2021-09-30 | -$1.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$980.00K derived: sum of 2 quarters · filed 2022-11-08 | -$344.00K 10-Q · filed 2022-11-08 | |
| 2021-06-30 | $273.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $909.00K 10-Q · filed 2022-08-02 | ||
| 2021-03-31 | $636.00K 10-Q · filed 2022-05-10 | |||
| 2020-09-30 | $1.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $2.56M derived: sum of 2 quarters · filed 2021-11-02 | $681.00K 10-Q · filed 2021-11-02 | |
| 2020-06-30 | $804.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | -$1.07M 10-Q · filed 2021-08-04 | ||
| 2020-03-31 | -$1.88M 10-Q · filed 2021-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |